INVESTER I CERIBELL MED ENDAVU: Køb Ceribell ($W3H) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Ceribell, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Ceribell, Inc. is a medical technology company specializing in AI-powered point-of-care electroencephalography systems for acute neurological care. The company’s core offering, the Ceribell System, is a rapidly deployable EEG platform designed for use in intensive care units, emergency departments, and other hospital settings where patients are at risk for seizures, status epilepticus, delirium, and other serious neurological conditions. Ceribell combines a disposable EEG headband, portable recording hardware, and bedside software with cloud connectivity and proprietary artificial intelligence algorithms to enable fast detection and continuous monitoring of suspected seizure activity. Its Clarity AI software supports real-time seizure-burden assessment at the bedside, helping clinicians triage patients more efficiently and integrate EEG into routine critical-care workflows. Ceribell operates today as a hybrid medical device and clinical software provider, focusing on neurodiagnostics and critical care monitoring across hospitals primarily in the United States. Founded in 2014 and headquartered in Sunnyvale, California, Ceribell plays a distinct role in the neurocritical care market by making EEG diagnostics more accessible, operationally efficient, and cost-effective at the point of care.